Equities research analysts at Wedbush reduced their Q2 2025 earnings per share (EPS) estimates for Meritage Homes in a report ...

Analysts at Wedbush boosted their Q1 2025 EPS estimates for shares of Alphabet in a research report issued on Wednesday, ...

Fintel reports that on February 6, 2025, Wedbush initiated coverage of Bicara Therapeutics (NasdaqGM:BCAX) with a Outperform ...

Dan Ives, Wedbush Securities managing director and global head of tech research, reacts to Amazon's first-quarter forecast. He speaks on "Bloomberg The Close." Amazon projected operating income of $14 ...

Revenue: Analysts tracked by FactSet expect $187.3 billion in revenue, up from $170.0 billion a year before. The FactSet consensus calls for 8.6% growth in North America revenue to $114.6 billion, 9.7 ...

Palantir trades at valuations such that the stock still looks richly valued even after hyperbolic growth in its business.

"The company is on a hell of a roll right now," one Wall Street analyst told me. Palantir's financial roll underscores the enthusiasm pushing its stock to meteoric heights. The company reported on Feb ...

In a report released today, Jay McCanless from Wedbush maintained a Hold rating on LGI Homes (LGIH – Research Report), with a price target of ...

In a report released today, Robert Driscoll from Wedbush maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target ...

In many ways, these have been tough days for Tesla. Falling sales. Squeezed profit margins. Proposed changes in US government ...